News
Being overweight or obese may lower all-cause mortality risks in non–cystic fibrosis (CF) bronchiectasis patients, while ...
More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially ...
Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis ...
Verona Pharma has seen its stock price jump by 125 percent year-to-date, closing at $104.74 versus $46.44 in the last trading ...
Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.
Paediatric-onset bronchiectasis leads to more severe disease than adult-onset, highlighting need for early, tailored care.
The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead ...
Patients with bronchiectasis face heightened risks of severe exacerbation and mortality after COVID-19 recovery, especially following severe cases.
16d
inews.co.uk on MSNThe incurable lung disease costing NHS £40m a year – but you’ve never heard of itBronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...
Background A range of questionnaires have been used to assess health-related quality of life (HRQOL) in bronchiectasis. A systematic review was conducted to evaluate their psychometric properties and ...
The "pulmonary rehabilitation pilot" is a special programme that combines exercise and education for sufferers of chronic obstructive pulmonary disease, asthma and bronchiectasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results